Trial intelligence / Profile preview

PK of Z7200 vs Symbicort in Healthy Volunteers

NCT02631941Phase 1Completed

Sponsor
Zambon
Start
Jan 2016
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of budesonide + formoterol in asthma (10 arms), sponsored by Zambon. Primary endpoints: Area Under the Curve from time 0 to last measurable concentration and Maximum Plasma Concentration. Started Jan 2016; status: completed.

02

Drugs

budesonide + formoterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT02631941.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02631941.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call